Neuronetics (STIM) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
31 May, 2026Opening remarks and agenda
Meeting conducted in a virtual-only format with rules of order available online.
Attendance included board members, executive officers, and external auditors.
Overview of voting outcomes
Quorum confirmed with proxies representing a majority of outstanding shares.
All seven director nominees re-elected to the board.
Appointment of KPMG as independent auditor for 2026 ratified.
Advisory approval of executive compensation and approval of the 2026 Equity Incentive Plan.
Final voting results to be filed with the SEC within four business days.
Q&A with stakeholders
No questions were submitted regarding voting matters or in the Q&A portal.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Neuronetics
- Q1 revenue up 8% to $34.5M, net loss narrows, but going concern risk remains.STIM
Q1 20266 May 2026 - Q4 2025 revenue up 86% YoY, positive cash flow, and 2026 guidance targets further growth.STIM
Q4 20251 May 2026 - Votes sought for director elections, auditor ratification, compensation, and equity plan.STIM
Proxy filing9 Apr 2026 - Annual meeting to vote on directors, auditor, executive pay, and new equity plan, with strong governance focus.STIM
Proxy filing9 Apr 2026 - Over 20 million shares registered for resale post-acquisition, with no proceeds to the company.STIM
Registration Filing17 Mar 2026 - Acquisition and integration of Greenbrook TMS set the stage for growth and operational synergies.STIM
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Record growth in new patient starts and adolescent market expansion set stage for 2025 breakeven.STIM
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q2 revenue fell 7% as net loss widened, but a major merger and new financing support future growth.STIM
Q2 20241 Feb 2026 - Q3 revenue up 4% to $18.5M; Greenbrook deal approved, cost synergies, break-even by 2025.STIM
Q3 202415 Jan 2026